FDA Drug Application (204031) for XARTEMIS XR by MALLINCKRODT INC

Back to FDA Applications sponsored by MALLINCKRODT INC

Application Number204031
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage325MG;7.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameXARTEMIS XR
Active IngredientACETAMINOPHEN; OXYCODONE HYDROCHLORIDE



Back to FDA Applications sponsored by MALLINCKRODT INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.